| Product Code: ETC12838562 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In the Poland influenza medications market, the import trend exhibited a notable growth rate of 14.4% from 2023 to 2024, with a compound annual growth rate (CAGR) of 10.44% for the period of 2020-2024. This import momentum can be attributed to an increased demand for pharmaceutical products, potentially driven by heightened health awareness and evolving treatment protocols in response to the pandemic.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Influenza Medications Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Poland Influenza Medications Market - Industry Life Cycle |
3.4 Poland Influenza Medications Market - Porter's Five Forces |
3.5 Poland Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Poland Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Poland Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Poland Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccinations. |
4.2.2 Growing elderly population in Poland, who are more susceptible to influenza. |
4.2.3 Rise in healthcare expenditure and government initiatives to control influenza outbreaks. |
4.3 Market Restraints |
4.3.1 Seasonal nature of influenza outbreaks, leading to fluctuations in demand for medications. |
4.3.2 Competition from alternative treatments and preventive measures like herbal remedies or lifestyle changes. |
5 Poland Influenza Medications Market Trends |
6 Poland Influenza Medications Market, By Types |
6.1 Poland Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Poland Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Poland Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Poland Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Poland Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Poland Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Poland Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Poland Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Poland Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Poland Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Poland Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Poland Influenza Medications Market Import-Export Trade Statistics |
7.1 Poland Influenza Medications Market Export to Major Countries |
7.2 Poland Influenza Medications Market Imports from Major Countries |
8 Poland Influenza Medications Market Key Performance Indicators |
8.1 Number of influenza vaccinations administered. |
8.2 Percentage of elderly population receiving influenza medications. |
8.3 Rate of government funding allocated for influenza prevention programs. |
9 Poland Influenza Medications Market - Opportunity Assessment |
9.1 Poland Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Poland Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Poland Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Poland Influenza Medications Market - Competitive Landscape |
10.1 Poland Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Poland Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here